You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Cloud based Application for the Joint Analysis of Multiple Big Data Types

    SBC: MathNimbus Inc            Topic: 400

    Project Summary Technology advances now enable the cost effective acquisition of Kandgt distinct data types from a common set of N bio samples where i the kth data type is represented by a data matrix with columns containing Pk measurements in N samples for k K and ii at least one of the data types is big i e Pk is much bigger than N for some k The rapid accumulation of such mult ...

    STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  2. Additive Manufacturing of Large Scale Heat Exchanger (Topic 18a)

    SBC: PHYSICAL SCIENCES INC.            Topic: 22a

    Nickel super alloys, such as Inconel®, are leading candidates for fossil energy-based power production components due to their resilience in extreme environments. A significant technical roadblock to the implementation of nickel-based power plant systems is the inability to produce large-scale components in a cost competitive manner. We will address the problem of manufacturing large, low-cost su ...

    STTR Phase I 2017 Department of Energy
  3. Advanced Compact X-Ray Spectrometer with High Resolution and Efficiency

    SBC: INCOM, INC.            Topic: 03a

    The combination of X-ray absorption spectroscopy (XAS) with x-ray emission spectroscopy (XES) provides unique diagnostic analysis of both the structure and chemical composition of complex heterogeneous materials. The penetration of X-rays make this method ideal for studying and optimizing material properties under realistic, real time reaction conditions with simultaneous analysis of r ...

    STTR Phase II 2014 Department of Energy
  4. Advanced Energy-Resolving Imaging Detectors for Applications at Pulsed Neutron Sources

    SBC: NOVA SCIENTIFIC INCORPORATED            Topic: 09a

    NOVA Scientific proposes the development of efficient position sensitive detectors capable of time-tagging epithermal energy neutrons with high accuracy and efficiency. These devices will be able to perform energy-resolved imaging at the pulsed neutron sources and detect every neutron with spatial resolution of & lt; 60 m and timing resolution & lt; 1 s for thermal neutrons and & lt;100 ns for epi ...

    STTR Phase II 2014 Department of Energy
  5. Advancing a novel portable detection method for cannabis intoxication

    SBC: Brain Solutions, LLC            Topic: NIDA

    Intoxication from marijuana MJ impairs psychomotor performance and at least doubles the risk of motor vehicle accidents The ongoing wave of legalization of MJ has brought increasing prevalence of driving while intoxicated with MJ However there is no quantitative biologic test that can accurately determine whether an individual is acutely impaired from MJ intoxication Assays of the primary in ...

    STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  6. A FAP-Activated Proteasome Inhibitor for Killing Solid Tumors

    SBC: ARISAPH PHARMACEUTICALS, INC.            Topic: 102

    DESCRIPTION provided by applicant Cancer is the second leading cause of death after heart disease in the US Chemotherapy is a mainstay of treatment after surgical removal of tumors but the balance of clinical benefit versus disabling or life threatening side effects is often uncertain Genotyping of cancers to identify mutated oncogenes has enabled an era of targeted therapy Drugs targeting ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  7. All-Electronic Gamma Rejection Method in Neutron Detection

    SBC: NOVA SCIENTIFIC INCORPORATED            Topic: 26c

    Neutron-sensitive microchannel Plates (MCPs) are now providing state-of-the-art user-based, high spatial resolution neutron imaging systems at several US government neutron research facilities as well as university research reactors. Using enriched 10B, thermalized neutron detection efficiencies exceeding 50% have been demonstrated, and cold neutron detection efficiencies of up to 70% have been do ...

    STTR Phase I 2017 Department of Energy
  8. Aminooxyacetic Acid Prodrugs for Colon Cancer Therapy

    SBC: CBS THERAPEUTICS, INC.            Topic: 102

    ABSTRACT Recent studies of the applicants support the role of the endogenous gaseous biological mediator hydrogen sulfide H S in colorectal cancer In specific the selective upregulation of cystathionine synthase CBS and the subsequent production of H S in colonic cancer cells serves as a pro survival factor by stimulating tumor cell bioenergetics ...

    STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  9. An eHealth solution for posttraumatic stress and pain screening integrated in pediatric injury care

    SBC: Radiant Creative Group, LLC            Topic: NICHD

    ABSTRACT Pediatric injury is the leading cause of child mortality and acquired disability in the United Statesaffectingmillion children annuallyAmong school age children alonemore thanmillion are treated in Emergency Department or admitted to the hospital annually for injuryincurring billions in medical and work loss costs each yearAfter hospital dischargemany injured children experience pain that ...

    STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  10. A New MicroRNA-1291 Replacement Therapy for Pancreatic Cancer Disease

    SBC: MIRNA THERAPEUTICS, INC.            Topic: NIAAA

    DESCRIPTION (provided by applicant): Pancreatic cancer is the fourth leading cause of cancer-related death in the United States. There is a clear need for more effective therapies to treat deadly pancreatic cancer disease. MicroRNAs (miRNA or miR) are a large group of short, noncoding RNAs that control posttranscriptional gene expression in human cells, and there is increasing evidence for the exi ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government